Literature DB >> 4152857

Effects of alpha- and beta-receptor blockade on systolic time intervals.

F Frei, P Imhof, U C Dubach.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4152857     DOI: 10.1007/bf00614383

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  45 in total

1.  THE EFFECT OF DIGITALIS ON VENTRICULAR EJECTION IN NORMAL HUMAN SUBJECTS.

Authors:  A M WEISSLER; W G GAMEL; H E GRODE; S COHEN; C D SCHOENFELD
Journal:  Circulation       Date:  1964-05       Impact factor: 29.690

2.  Peripheral venoconstriction during acceleration and orthostasis.

Authors:  S D LEVERETT; E W SALZMAN
Journal:  Circ Res       Date:  1956-09       Impact factor: 17.367

3.  Hemodynamic effects of practolol at rest and during exercise.

Authors:  D F Leon; M E Thompson; J A Shaver; R H McDonald
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

4.  A comparison between the effects of dynamic and isometric exercise as evaluated by the systolic time intervals in normal man.

Authors:  V A Lindquist; R D Spangler; S G Blount
Journal:  Am Heart J       Date:  1973-02       Impact factor: 4.749

5.  Left ventricular systolic time intervals as indices of postural circulatory stress in man.

Authors:  R W Stafford; W S Harris; A M Weissler
Journal:  Circulation       Date:  1970-03       Impact factor: 29.690

6.  The influence of beta-adrenergic receptor blockade on circulatory function tests (orthostatic reaction, Valsalva's manoeuvre and response to vasopressor substances).

Authors:  B Garnier; P R Imhof
Journal:  Mal Cardiovasc       Date:  1967

7.  Appraisal and reappraisal of cardiac therapy. Edited by Arthur C. DeGraff, Alan F. Lyon, and Julian Frieden. Phentolamine.

Authors:  L Gould
Journal:  Am Heart J       Date:  1969-08       Impact factor: 4.749

8.  Effect of different degrees of tilt on cardiac output, heart rate, and blood pressure in normal man.

Authors:  J Tuckman; J Shillingford
Journal:  Br Heart J       Date:  1966-01

9.  Myocardial and haemodynamic effects of phentolamine.

Authors:  P K Das; J R Parratt
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739

10.  Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man.

Authors:  W S Harris; C D Schoenfeld; A M Weissler
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

View more
  7 in total

1.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology.

Authors:  S Hassan; P Turner
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

3.  Cardiac effects of tricyclic antidepressant medication. A preliminary study of nortriptyline.

Authors:  D J Taylor; R A Braithwaite
Journal:  Br Heart J       Date:  1978-09

4.  Systolic time intervals--correction for heart rate.

Authors:  G K Wolf; G G Belz; M Stauch
Journal:  Basic Res Cardiol       Date:  1978 Jan-Feb       Impact factor: 17.165

5.  Estimation of the plasma concentration and course of action of phentolamine based on its inhibitory effect on adrenaline-induced platelet aggregation.

Authors:  B Pfister; P Imhof
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

6.  Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension.

Authors:  J F Winchester; D M Ward; J H McKillop; A C Kennedy
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

7.  Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man.

Authors:  L Brunner; P Imhof; D Jack
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.